The Safetyof Dabigatran Versus Warfarin in Patients Undergoing Atrial Fibrillation Ablation

The safety and optimal strategy of the use of dabigatran versus uninterrupted warfarin in atrial fibrillation ablation is currently unclear. We performed a retrospective analysis between July 2011-October 2012 of all patients undergoing an AF ablation who received uninterrupted warfarin therapy (199...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Atr Fibrillation
Autors principals: Garcia, Luis I, Mascarenhas, Mark A, Ahuja, Kartikya, Aizer, Anthony, Bernstein, Neil, Bernstein, Scott A, Fowler, Steve J, Holmes, Douglas S, Park, David S, Chinitz, Larry
Format: Artigo
Idioma:Inglês
Publicat: Cardiofront, Inc 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956124/
https://ncbi.nlm.nih.gov/pubmed/27957036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.965
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars